Search results
Results From The WOW.Com Content Network
The International AIDS Conference (abbreviated AIDS 2012, AIDS 2014 and so on) is the world's most attended conference on HIV and AIDS, and the largest conference on any global health or development issue in the world. [7] First convened during the peak of the AIDS epidemic in 1985, they were held annually until 1994 when they became biennial.
The Conference on Retroviruses and Opportunistic Infections (CROI) is an annual scientific meeting devoted to the understanding, prevention and treatment of HIV/AIDS and the opportunistic infections associated with AIDS. Thousands of leading researchers and clinicians from around the world convene in a different location in North America each ...
In 2016 she was elected President of the International AIDS Society. [21] She gave the opening address at the International AIDS Society Conference in Paris, where she spoke about new prevention options such as Pre-exposure prophylaxis. [22] In 2018 she was elected to the board of the International AIDS Vaccine Initiative. [14]
The venue has hosted various high-level conferences and meetings since its inception, namely: the International AIDS Conference in 2000 and again in July 2016; the 1999 Commonwealth Heads of Government Meeting; and the Non-Aligned Movement in 2004.
X International AIDS Conference, 1994; XI International AIDS Conference, 1996; XII International AIDS Conference, 1998; XIII International AIDS Conference, 2000; XIV International AIDS Conference, 2002; XV International AIDS Conference, 2004; XVI International AIDS Conference, 2006; XVII International AIDS Conference, 2008; XVIII International ...
International AIDS Conferences (16 P) B. International business conferences (5 P) F. FIFA Congresses (9 P) G. ... International Conference of Women Engineers and ...
At the 2024 International AIDS Conference, PrEP with long-acting injectable cabotegravir (CAB-LA; Apretude) appears safe during pregnancy among cisgender women, according to an analysis from the HPTN 084 open-label extension trial. [120]
At the recent 2024 International AIDS Conference in Munich urged Gilead Sciences to allow Lenacapavir to have generic licensing access to the UN-backed Medicines Patent Pool so that whereby cheaper generic versions could be sold under licence in low- and middle-income countries similar to Gilead Sciences existing relationships with the MPP and ...